Birgit Högl

Research interests

Publications

• The need to promote sleep health in public health agendas across the globe

  The Lancet Public Health · 2023 · https://doi.org/10.1016/s2468-2667(23)00182-2

• Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder

  The Lancet Neurology · 2021 · 10.1016/s1474-4422(21)00176-9

• Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study

  Brain · 2019 · https://doi.org/10.1093/brain/awz030

• The European Academy for Cognitive Behavioural Therapy for Insomnia: An initiative of the European Insomnia Network to promote implementation and dissemination of treatment

  Journal of Sleep Research · 2019 · 10.1111/jsr.12967

• Sleep in Parkinson’s disease

  Neuropsychopharmacology · 2019 · https://doi.org/10.1038/s41386-019-0448-y

• Comorbidities, treatment, and pathophysiology in restless legs syndrome

  The Lancet Neurology · 2018 · 10.1016/s1474-4422(18)30311-9

• Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy

  Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-07229-3

• Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis

  The Lancet Neurology · 2017 · https://doi.org/10.1016/s1474-4422(17)30327-7

• Idiopathic REM sleep behaviour disorder and neurodegeneration — an update

  Nature Reviews Neurology · 2017 · https://doi.org/10.1038/nrneurol.2017.157

• Clinical manifestations of the anti-IgLON5 disease

  Neurology · 2017 · https://doi.org/10.1212/wnl.0000000000003887

• Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation

  Sleep Medicine · 2016 · https://doi.org/10.1016/j.sleep.2016.01.017

• Restless legs syndrome associated with major diseases

  Neurology · 2016 · https://doi.org/10.1212/wnl.0000000000002542

• Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study

  Annals of Neurology · 2015 · https://doi.org/10.1002/ana.24385

• DQB1 Locus Alone Explains Most of the Risk and Protection in Narcolepsy with Cataplexy in Europe

  SLEEP · 2014 · https://doi.org/10.5665/sleep.3300

• Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group

  Sleep Medicine · 2013 · https://doi.org/10.1016/j.sleep.2013.02.016

• The long-term treatment of restless legs syndrome/Willis–Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group

  Sleep Medicine · 2013 · https://doi.org/10.1016/j.sleep.2013.05.016

• ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy

  PLoS Genetics · 2013 · https://doi.org/10.1371/journal.pgen.1003270

• Normative EMG Values during REM Sleep for the Diagnosis of REM Sleep Behavior Disorder

  SLEEP · 2012 · https://doi.org/10.5665/sleep.1886

• A single‐question screen for rapid eye movement sleep behavior disorder: A multicenter validation study

  Movement Disorders · 2012 · https://doi.org/10.1002/mds.25037

• Parkinson's disease sleep scale—validation of the revised version PDSS‐2

  Movement Disorders · 2011 · https://doi.org/10.1002/mds.23476

• Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study

  The Lancet Neurology · 2010 · https://doi.org/10.1016/s1474-4422(10)70216-7

• Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations

  Movement Disorders · 2010 · 10.1002/mds.23190

• Narcolepsy is strongly associated with the T-cell receptor alpha locus

  Nature Genetics · 2009 · https://doi.org/10.1038/ng.372

• PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome

  Nature Genetics · 2008 · https://doi.org/10.1038/ng.190

• Diagnostic Standards for Dopaminergic Augmentation of Restless Legs Syndrome: Report from a World Association of Sleep Medicine – International Restless Legs Syndrome Study Group Consensus Conference at the Max Planck Institute

  Sleep Medicine · 2007 · https://doi.org/10.1016/j.sleep.2007.03.022

• Restless legs syndrome

  Neurology · 2005 · https://doi.org/10.1212/01.wnl.0000163996.64461.a3

• Prevalence of movement disorders in men and women aged 50–89 years (Bruneck Study cohort): a population-based study

  The Lancet Neurology · 2005 · https://doi.org/10.1016/s1474-4422(05)70226-x

• Modafinil for the Treatment of Daytime Sleepiness in Parkinson´s Disease: A Double-blind, Randomized, Crossover, Placebo-controlled Polygraphic Trial

  SLEEP · 2002 · 10.1093/sleep/25.8.62

Current projects

No projects listed.